Cargando…

Genomic reconstruction of short-chain fatty acid production by the human gut microbiota

Short-chain fatty acids (SCFAs) including acetate, formate, propionate, and butyrate are the end products of dietary fiber and host glycan fermentation by the human gut microbiota (HGM). SCFAs produced in the column are of utmost importance for host physiology and health. Butyrate and propionate imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Frolova, Maria S., Suvorova, Inna A., Iablokov, Stanislav N., Petrov, Sergei N., Rodionov, Dmitry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403272/
https://www.ncbi.nlm.nih.gov/pubmed/36032669
http://dx.doi.org/10.3389/fmolb.2022.949563
_version_ 1784773337475448832
author Frolova, Maria S.
Suvorova, Inna A.
Iablokov, Stanislav N.
Petrov, Sergei N.
Rodionov, Dmitry A.
author_facet Frolova, Maria S.
Suvorova, Inna A.
Iablokov, Stanislav N.
Petrov, Sergei N.
Rodionov, Dmitry A.
author_sort Frolova, Maria S.
collection PubMed
description Short-chain fatty acids (SCFAs) including acetate, formate, propionate, and butyrate are the end products of dietary fiber and host glycan fermentation by the human gut microbiota (HGM). SCFAs produced in the column are of utmost importance for host physiology and health. Butyrate and propionate improve gut health and play a key role in the neuroendocrine and immune systems. Prediction of HGM metabolic potential is important for understanding the influence of diet and HGM-produced metabolites on human health. We conducted a detailed metabolic reconstruction of pathways for the synthesis of SCFAs and L- and D-lactate, as additional fermentation products, in a reference set of 2,856 bacterial genomes representing strains of >800 known HGM species. The reconstructed butyrate and propionate pathways included four and three pathway variants, respectively, that start from different metabolic precursors. Altogether, we identified 48 metabolic enzymes, including five alternative enzymes in propionate pathways, and propagated their occurrences across all studied genomes. We established genomic signatures for reconstructed pathways and classified genomes according to their simplified binary phenotypes encoding the ability (“1”) or inability (“0”) of a given organism to produce SCFAs. The resulting binary phenotypes combined into a binary phenotype matrix were used to assess the SCFA synthesis potential of HGM samples from several public metagenomic studies. We report baseline and variance for Community Phenotype Indices calculated for SCFAs production capabilities in 16S metagenomic samples of intestinal microbiota from two large national cohorts (American Gut Project, UK twins), the Hadza hunter-gatherers, and the young children cohort of infants with high-risk for type 1 diabetes. We further linked the predicted SCFA metabolic capabilities with available SCFA concentrations both for in vivo fecal samples and in vitro fermentation samples from previous studies. Finally, we analyzed differential representation of individual SCFA pathway genes across several WGS metagenomic datasets. The obtained collection of SCFA pathway genes and phenotypes enables the predictive metabolic phenotype profiling of HGM datasets and enhances the in silico methodology to study cross-feeding interactions in the gut microbiomes.
format Online
Article
Text
id pubmed-9403272
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94032722022-08-26 Genomic reconstruction of short-chain fatty acid production by the human gut microbiota Frolova, Maria S. Suvorova, Inna A. Iablokov, Stanislav N. Petrov, Sergei N. Rodionov, Dmitry A. Front Mol Biosci Molecular Biosciences Short-chain fatty acids (SCFAs) including acetate, formate, propionate, and butyrate are the end products of dietary fiber and host glycan fermentation by the human gut microbiota (HGM). SCFAs produced in the column are of utmost importance for host physiology and health. Butyrate and propionate improve gut health and play a key role in the neuroendocrine and immune systems. Prediction of HGM metabolic potential is important for understanding the influence of diet and HGM-produced metabolites on human health. We conducted a detailed metabolic reconstruction of pathways for the synthesis of SCFAs and L- and D-lactate, as additional fermentation products, in a reference set of 2,856 bacterial genomes representing strains of >800 known HGM species. The reconstructed butyrate and propionate pathways included four and three pathway variants, respectively, that start from different metabolic precursors. Altogether, we identified 48 metabolic enzymes, including five alternative enzymes in propionate pathways, and propagated their occurrences across all studied genomes. We established genomic signatures for reconstructed pathways and classified genomes according to their simplified binary phenotypes encoding the ability (“1”) or inability (“0”) of a given organism to produce SCFAs. The resulting binary phenotypes combined into a binary phenotype matrix were used to assess the SCFA synthesis potential of HGM samples from several public metagenomic studies. We report baseline and variance for Community Phenotype Indices calculated for SCFAs production capabilities in 16S metagenomic samples of intestinal microbiota from two large national cohorts (American Gut Project, UK twins), the Hadza hunter-gatherers, and the young children cohort of infants with high-risk for type 1 diabetes. We further linked the predicted SCFA metabolic capabilities with available SCFA concentrations both for in vivo fecal samples and in vitro fermentation samples from previous studies. Finally, we analyzed differential representation of individual SCFA pathway genes across several WGS metagenomic datasets. The obtained collection of SCFA pathway genes and phenotypes enables the predictive metabolic phenotype profiling of HGM datasets and enhances the in silico methodology to study cross-feeding interactions in the gut microbiomes. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9403272/ /pubmed/36032669 http://dx.doi.org/10.3389/fmolb.2022.949563 Text en Copyright © 2022 Frolova, Suvorova, Iablokov, Petrov and Rodionov. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Frolova, Maria S.
Suvorova, Inna A.
Iablokov, Stanislav N.
Petrov, Sergei N.
Rodionov, Dmitry A.
Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title_full Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title_fullStr Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title_full_unstemmed Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title_short Genomic reconstruction of short-chain fatty acid production by the human gut microbiota
title_sort genomic reconstruction of short-chain fatty acid production by the human gut microbiota
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403272/
https://www.ncbi.nlm.nih.gov/pubmed/36032669
http://dx.doi.org/10.3389/fmolb.2022.949563
work_keys_str_mv AT frolovamarias genomicreconstructionofshortchainfattyacidproductionbythehumangutmicrobiota
AT suvorovainnaa genomicreconstructionofshortchainfattyacidproductionbythehumangutmicrobiota
AT iablokovstanislavn genomicreconstructionofshortchainfattyacidproductionbythehumangutmicrobiota
AT petrovsergein genomicreconstructionofshortchainfattyacidproductionbythehumangutmicrobiota
AT rodionovdmitrya genomicreconstructionofshortchainfattyacidproductionbythehumangutmicrobiota